Go to article
Posted by CoV Report on November 26, 2021 7:31 amTags: Categories: Global Stories
The company said the data on the drug molnupiravir had been submitted to the U.S. Food and Drug Administration ahead of a meeting of its expert advisers on Tuesday.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply